Novartis AG CEO Vas Narasimhan tells Bloomberg Television that the drugmaker is in talks with "a range of different players" to help produce other companies’ Covid-19 vaccines or treatments, potentially adding another pharma giant’s resources to boost supply as fights over access to doses intensify. (Source: Bloomberg)